Publications
2023
Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells.
Mok, M. Y., Law, K. S., Kong, W. Y., Luo, C. Y., Asfaw, E. T., Chan, K. W., . . . Chan, G. C. F. (2023). Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells.. Journal of innate immunity, 15(1), 485-498. doi:10.1159/000529931
2021
Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid Leukaemia
Clark, R. E., Basabrain, A. A., Austin, G. M., Holcroft, A. K., Loaiza, S., Apperley, J. F., . . . Lucas, C. M. (2021). Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid Leukaemia. CANCERS, 13(9). doi:10.3390/cancers13092155
2016
Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.
Chu, W. K., Law, K. S., Chan, S. O., Yam, J. C. S., Chen, L. J., Zhang, H., . . . Pang, C. P. (2016). Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.. Proceedings of the National Academy of Sciences of the United States of America, 113(50), 14396-14401. doi:10.1073/pnas.1617427113
Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
Wu, H., Lo, Y., Chan, A., Law, K. S., & Mok, M. Y. (2016). Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.. Immunology, 149(1), 48-61. doi:10.1111/imm.12628